MyMD Pharmaceuticals Inc (MYMD)

[BioFan1]

Friends: don't expect news. All the news is already out there, in the form of multiple, peer reviewed, scientific reports and prestigious Journal articles showing this compound has the potential to revolutionize healthcare. It's just that until now, no one who matters has noticed, because all biotech firms with no revenue are suspect. The suppression of TFN alpha and associated inflammatory processes, especially without horrible side effects (e.g., like those accompanying Humera) is a holy grail of medicine. MYMD is safe (it breezed through Phase 1) and has been shown to significantly lower TFN alpha.

All biotechs are to some degree a speculative bet. But would you rather bet on a compound that treats some obscure disease (or one type of cancer) or one that might treat every inflammatory disease known to man, from arthritis to diabetes. My money (and it's a big chunk of it) is on MYMD.

The action today suggests that some big hitters are figuring this out. It also suggests that all the sellers are gone.